COMMUNIQUÉS West-GlobeNewswire

SIGA Technologies Announces Favorable Outcome of Advisory Committee In Support of TPOXX®
01/05/2018
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA ), a health security company specializing in the development and commercialization of solutions for serious unmet medical needs and [...]
Galapagos and MorphoSys announce initiation of the IGUANA Phase 2 clinical trial with MOR106 in atopic dermatitis patients
01/05/2018
Mechelen, Belgium and Planegg/Munich, Germany; 1 May 2018; 22.01 CET - Galapagos NV (Euronext & NASDAQ: GLPG) and MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) announced today that the first [...]
Dermira to Present at Deutsche Bank 43rd Annual Healthcare Conference
01/05/2018
MENLO PARK, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Mersana Therapeutics to Present at the Deutsche Bank 43rd Annual Health Care Conference
01/05/2018
CAMBRIDGE, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN ), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]
Paratek Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
01/05/2018
BOSTON, May 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
Teladoc Announces First Quarter 2018 Results
01/05/2018
1Q 2018 Revenue of $89.6 million, growth of 109% Total Paid Membership of 20.8 million, growth of 41% 1Q 2018 Total Visits of 606,000, growth of 57% PURCHASE, NY, May 01, 2018 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE: [...]
Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results and Provide Corporate Update
01/05/2018
BURNABY, British Columbia, May 01, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2018 financial [...]
Retrophin Reports First Quarter 2018 Financial Results
01/05/2018
Company obtains FDA and EMA feedback on pathway to NDA and MAA filing for sparsentan in IgA nephropathy; single Phase 3 trial expected to initiate in the fourth quarter of 2018 Pivotal Phase 3 DUPLEX Study of sparsentan [...]
Trevena Inc. and Jiangsu Nhwa Pharmaceutical Co. Ltd Announce License Agreement for Oliceridine in China
01/05/2018
– Nhwa granted a license to develop, manufacture, and commercialize oliceridine in China – – Trevena to receive upfront and milestone payments and royalties – CHESTERBROOK, Pa. and XUZHOU, China, May 01, 2018 (GLOBE [...]
CytomX Therapeutics to Announce First Quarter 2018 Financial Results
01/05/2018
SOUTH SAN FRANCISCO, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX ), a clinical-stage biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of [...]
Endocyte to Present at Deutsche Bank's 43rd Annual Health Care Conference
01/05/2018
WEST LAFAYETTE, Ind., May 01, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company’s [...]
TOMI Environmental Solutions, Inc. Achieves Royal Success Using SteraMist™ for Metropolitan Police Project
01/05/2018
BEVERLY HILLS, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global provider of infection prevention and decontamination products, services and research, including [...]
CORRECTION: Polydex Pharmaceuticals Provides Year End Financial Report
01/05/2018
Margins Maintained, EBITDA Remains Strong TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC/Pink:POLXF) (the “Company”) reports financial results for its fiscal year ended January 31, 2018. [...]
Spinogenix Awarded NIH Grant to Develop Novel Neurorestorative Therapeutics for Alzheimer’s Disease
01/05/2018
SAN DIEGO, May 01, 2018 (GLOBE NEWSWIRE) -- Spinogenix, Inc., a preclinical stage, privately-held pharmaceutical company developing first-in-class drugs to reverse synapse loss and restore connections lost to [...]
MPI - NOTICE TO CONVENE EXTRAORDINARY GENERAL MEETING
01/05/2018
Indkaldelse til ekstraordinær generalforsamling Notice to convene extraordinary general meeting Der indkaldes herved til ekstraordinær generalforsamling i Medical Prognosis Institute A/S ("Selskabet"): Notice is hereby [...]
LifeLabs Announces New President and CEO
01/05/2018
Toronto, ON, May 01, 2018 (GLOBE NEWSWIRE) -- LifeLabs, Canada’s largest medical laboratory, has announced its new President and CEO with the appointment of Charles Brown, an accomplished executive with a demonstrated [...]
Eloxx Pharmaceuticals To Report First Quarter 2018 Financial Results On May 10, 2018 and Host Webcast and Conference Call
01/05/2018
WALTHAM, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”), (Nasdaq: ELOX ) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to [...]
Lumere, AHVAP Announce Partnership to Highlight Best Practices in Managing Care Variation
01/05/2018
CHICAGO, May 01, 2018 (GLOBE NEWSWIRE) -- Lumere, a leading provider of data-driven analytics, evidence and expert guidance to help health systems reduce unwarranted clinical variation, today announced plans to [...]
Polydex Pharmaceuticals Provides Year End Financial Report
01/05/2018
Margins Maintained, EBITDA Remains Strong TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink:POLXF) (the “Company”) reports financial results for its fiscal year ended January 31, 2018. [...]

Pages